ストックスクリーナーアプリを入手
21.96
0.92%
0.20
前日終値:
$21.76
開ける：
$21.51
24時間の取引高:
22.65M
Relative Volume:
4.46
時価総額：
$11.27B
収益：
$11.89B
当期純損益:
$-560.00M
株価収益率:
-19.96
EPS:
-1.1
ネットキャッシュフロー:
$191.00M
1週間 パフォーマンス:
-24.85%
1か月 パフォーマンス:
-29.68%
6か月 パフォーマンス:
-32.56%
1年 パフォーマンス:
-39.02%
1日の値動き範囲:
$21.33
$22.36
1週間の範囲:
$21.33
$29.35
52週間の値動き範囲:
$21.33
$40.49
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
21.96 | 11.17B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
483.12 | 172.46B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
176.37 | 51.09B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.87 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
279.20 | 39.87B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga
Why is Baxter International Inc. stock attracting strong analyst attentionHigh-yield portfolio picks - jammulinksnews.com
What drives Baxter International Inc. stock priceGet daily updates on market movers and shakers - jammulinksnews.com
What are Baxter International Inc. company’s key revenue driversHigh-octane gains - jammulinksnews.com
How does Baxter International Inc. compare to its industry peersAchieve superior returns through strategic trading - jammulinksnews.com
What catalysts could drive Baxter International Inc. stock higher in 2025Invest with confidence backed by data - jammulinksnews.com
Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast - MSN
Baxter International (NYSE:BAX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Baxter International (NYSE:BAX) Price Target Lowered to $24.00 at Wells Fargo & Company - MarketBeat
Baxter International (NYSE:BAX) Cut to "Neutral" at The Goldman Sachs Group - MarketBeat
Wall Street Zen Downgrades Baxter International (NYSE:BAX) to Hold - MarketBeat
What are the technical indicators suggesting about Baxter International Inc.Entry Signal Tracker With Proven Results - jammulinksnews.com
Baxter cut to Neutral at Goldman Sachs after Q2 miss - MSN
Baxter stock cut to Neutral at Goldman Sachs (BAX:NYSE) - Seeking Alpha
Baxter cuts financial forecast while pausing infusion pump shipments - Fierce Biotech
Medical products maker Baxter cuts 2025 forecast; shares plunge to 19-year low - MSN
Baxter International (NYSE:BAX) Issues Q3 2025 Earnings Guidance - MarketBeat
Baxter International (NYSE:BAX) Releases FY 2025 Earnings Guidance - MarketBeat
Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Call Transcript - Insider Monkey
Baxter Q2 2025 sales up 4% to USD 2.81B - Medical Buyer
Hurricane Setback Batters Baxter International’s Earnings Forecast - Finimize
Pacer Advisors Inc. Sells 14,914 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc (BAX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid Operational Challenges - GuruFocus
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Baxter International Reports Steady Q2 2025 Growth - TipRanks
Baxter International’s Mixed Earnings Call Highlights Growth and Challenges - TipRanks
Baxter Healthcare – Building supply resilience for Australian healthcare - Manufacturers' Monthly
Baxter Shares Slide As Earnings And Forecast Disappoint - Finimize
Baxter International Inc Options Spot-On: On July 31st, 222.65K Contracts Were Traded, With 75,527 Open Interest - 富途牛牛
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Baxter lowers operational sales growth outlook to 3%-4% for 2025 amid Novum pause and fluid conservation - MSN
Baxter International's Q2 Earnings Miss and Strategic Crossroads: Navigating Operational Challenges and Leadership Transition in a Weak Industry Environment - AInvest
Baxter halts infusion pump shipments, slashes 2025 sales forecast - Modern Healthcare
Baxter Stock Falls To 52-Week Low On Trimmed Annual OutlookBaxter Intl (NYSE:BAX) - Benzinga
Why Baxter (BAX) Stock Is Falling Today - Yahoo Finance
Baxter Still in Turnaround Mode, Awaiting Impact From New CEO - Morningstar
Baxter slumps as Medical Products & Therapies drive Q2 revenue miss - MSN
Baxter International Inc.'s 2025 Q2 Earnings: A Blueprint for Long-Term Growth Through Efficiency, Innovation, and Global Expansion - AInvest
Baxter International Q2 2025 Earnings Call Transcript: Key Highlights and Financial Outlook - AInvest
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates - Yahoo Finance
RSI Alert: Baxter International Now Oversold - Nasdaq
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down - TradingView
Baxter stock plunges as FDA scrutiny, lingering storm fallout damage outlook - Crain's Chicago Business
Baxter International stock slumps on Q2 miss (BAX:NYSE) - Seeking Alpha
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit - The Mighty 790 KFGO
Baxter International Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Baxter International's Q2 2025 Earnings: A Tale of Revenue Growth and Profitability Struggles - AInvest
Baxter’s (NYSE:BAX) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops - TradingView
Baxter Q2 2025 slides trigger selloff despite strong Q1 performance By Investing.com - Investing.com Nigeria
Baxter Earnings Slip Below Forecasts As Outlook Gets Trimmed - Finimize
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
大文字化:
|
ボリューム (24 時間):